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In previous work from this laboratory (1) it was shown that a considerable 
portion of an intravenously injected antigen, bovine serum albumin (BSA), 
circulated in a globulin-bound  form during the immune phase in rabbits. This 
globulin-bound BSA in all likelihood represented circulating antigen-antibody 
complexes. In further studies (2, 3),  it was shown that the lesions found in 
rabbits with experimental serum sickness developed during the time that the 
antigen-antibody complexes  were circulating. Further, it was postulated by 
Germuth (4) and by us (2, 3),  that these soluble complexes were responsible, 
at least in part, for the lesions of serum sickness. However, whether soluble 
complexes could bring about pathologic changes in tissues was not known. 
An  investigation  was  therefore undertaken to  test  the  effect of  soluble 
antigen-antibody complexes on tissues in vivo. This was performed by injecting 
• rabbits intracutaneously at various dosage levels. The complexes were prepared 
in a relatively pure form by precipitating the antibody with antigen at equiva- 
lence, washing the precipitate, and finally dissolving the precipitate in antigen 
excess. This was done to exclude factors in serum other than antibody which 
might influence the reactions. Amounts, in terms of antibody, were used to 
equal  those required to  produce minimal to  maximal local  passive  Arthus 
reactions (5). The lesions produced by the soluble  complexes were compared 
quantitatively and qualitatively with  (a)  the local  passive  Arthus,  (b)  the 
reversed passive Arthus, and (c) the active or classical Arthus reactions. 
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The  in  dvo  effect  of  soluble antigen-antibody complexes  has  been  studied  by 
others. Opie (6) in 1924 reported that a  combination of horse serum and anti-horse 
serum when injected intradermally into rabbits caused local inflammation. Germuth 
and McKinnon (7) studied the effect of soluble antigen-antibody complexes prepared 
in antigen excess following intravenous injection into guinea pigs. They found varying 
degrees of anaphylactic shock in 133 of 162 animals. Trapani, Garvey, and Campbell 
(8), and Ishiza.ka and Campbell (9), have recently reported that the activity of sol- 
uble complexes is greatest when prepared in antigen excess. In three sera used  (9), 
it was shown that when complexes were made from a  slow gamma component of the 
antisera, activity occurred in antigen excess only. Their evidence is based both on 
experiments utilizing the contraction of guinea pig ileum with a  Schultz-Dale tech- 
nique and also on experiments resulting in increased capillary permeability in guinea 
pig skin following intradermal injection of the soluble complexes. Tokuda and Weiser 
(10)  have  recently reported  that  antigen-antibody complexes prepared  in  antigen 
excess produced anaphylaxis in mice. 
In 1924, Opie (6) by relating intensity of the cutaneous reaction with the precipitin 
titer  demonstrated  the  antigen-antibody nature  of  the  Arthus  phenomenon.  This 
was confirmed by Culbertson (11) and Cannon and Marshall (12). Antigen and anti- 
body have been used  in various combinations and  injected da  different routes  to 
produce antigen-antibody reactions in the skin (5, 6, 11-15). However, the actual site 
of combination of antigen and antibody in the cutaneous tissue is unknown, and a 
part of this study was therefore undertaken to find the in dvo localization of these 
various reactants using the fluorescent antibody technique of Coons and Kaplan (16). 
Materials and Methods 
Preparation  of Soluble Antigen-Antibody  Complexes.--Antiserum  to  crystallized bovine 
serum albumin (BSA  1) was obtained from repeated courses of injections of reline solutions of 
BSA in rabbits. The anti-BSA sera were pooled and analyzed for antibody nitrogen by the 
quantitative precipitin method (17). Various pools used contained 0.50,  1.38, and 1.48 rag. 
antibody nitrogen (Ab N) per mi. All sera were kept frozen at --20°C. until used. To prepare 
the soluble complexes, an amount of BSA antigen was added to antisera to reach the point 
of equivalence.  The combination was then incubated at 37°C. for one-half hour and then 
refrigerated at 0 to 3°C. overnight.  The precipitate thus formed was washed three times with 
0.15 ~  saline at 0 to 1°C. An additional amount of BSA was then added so that the total 
amount of BSA in the system equalled three to four times that needed for precipitation at 
equivalence. After incubation at 37°C. for an hour, the precipitate dissolved in the existing 
antigen excess. Occasionally a longer period of time was required to dissolve the precipitate, 
the complexes then being stored in the cold until a solution was achieved. The soluble com- 
plexes thus formed were used for injection. 
Method of Injection and Grading of Reactions.--Male  albino rabbits and guinea pigs were 
used in each experiment.  Injections were made on the flanks in all cases 24 hours after re- 
moving the hair with electric hair clippers. No differences in reaction intensity were detected 
when  the site of injection was varied. Volume of injected materials was less than 0.3  mi. 
unless otherwise specified. The intensity of maximal reaction was graded as follows:-- 
q-, mild edema and erythema equal in intensity to the reaction obtained by injection of 
an equal volume of antigen or antiserum. 
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+, mild edema with erythema  both lasting 24 hours and measuring 1.5 cm. in greatest 
diameter. 
++,  mild to moderated edema, erythenm measuring more than 3 cm. in greatest  diam- 
eter; brownish discoloration measuring up to 0.5 cm. 
+++,  moderate edema; erythema measuring 3 to 4 cm.; hemorrhage and brownish dis- 
coloration measuring 0.5 to 1.5 cm. in diameter. 
++++,  severe edema; marked erythema and hemorrhage measuring more than 1.5 cm.; 
sloughing of reaction site. 
This system of grading is similar to that of Opie (6) in which sloughing is required for the 
+ + + +  designation. 
Injections of soluble complexes were performed using the quantities of antigen and anti- 
body listed below.  The reactions produced were compared in the gross andmicroscopically  to the 
three other types of cutaneous antigen-antibody reactions mentioned, the BSA rabbit anti- 
BSA system being used throughout:  (a)  the local passive Arthns (LPA) in which antiserum 
of known antibody content was injected intradermally followed within 30 to 60 minutes by a 
superimposed intmdermal injection of the antigen, 0.25 rag. BSA nitrogen (BSA N); (b)  the 
reversed passive Arthus (RPA) in which, in all cases, 8 nag. BSA hl was injected intravenously 
followed in one-half to one hour by an intradermal injection of known quantifies of antiserum; 
(c)  classical or active Arthus reactions in which highly sensitized rabbits were injected intra- 
dermally with 0.18 rag. BSA N. 
The following control injections were performed in normal, unsensitized rabbits: (a)  0.3 
ml. antiserum, (4 rabbits); (b)  180 ~g. BSA hi contained in either 0.3 or 0.4 ml. 0.15 M  hiaC1 
or 0.3 nil. normal rabbit serum, (4 rabbits); (¢)  a 0.15 M  hiaC1 suspension of antigen-antibody 
(BSA-anti BSA) precipitate  containing 2.5 rag. Ab hi, which was prepared  at equivalence 
and washed twice with 0.15 ~r hiaC1 at 0-2°C., (5 rabbits); and (d)  a saline suspension of 2.7 
rag. N of heat denatured BSA, prepared by heating BSA in saline to 100°C. for less than one 
minute, centrifuging off, and finally washing the insoluble, denatured protein twice with 0.15 
NaCI at 0-2°C., (5 rabbits). Biopsies of all control tissues were taken. 
All spedmens  of cutaneous tissues procurred by biopsy were taken in duplicate; half of 
each specimen was fixed in 10 per cent formalin for 24 hours for routine histologic sections 
while the opposite half specimen was frozen at --70°C. in a mixture of butylalcohol and solid 
carbon dioxide. 
Fluorescent Antibody Te~kni~lue.--The frozen specimens were studied  for localization of 
antigen and rabbit globulin using the fluorescent antibody technique of Coons and Kaplan 
(16), with certain modifications as noted in previous publications from this laboratory  (18, 
19).  t Ethanol fracfionation of the fluorescein:conjugated antiserum was found unnecessary 
and was  dispensed with.  Adsorption  with  acetone-dried liver powder was  performed by 
shaking the conjugates with the powder, 150 rag. powder per 1 mi. of conjugate, for 1 hour at 
room temperature.  The powder was then removed by centrifugation leaving a clear solution 
for use. 
P~SULTS 
1.  G~oss Re~tio~.--Intradermal  injections of soluble complexes were per- 
formed using doses of 0.03,  0.30,  0.43, 0.65,  1.20 and 2.66 rag.  Ab N.  In all 
instances the reaction first became apparent in the gross at about 5 hours after 
injection, reaching a  maximum at 20 to 24 hours and decreasing in intensity 
thereafter. Maximal reactions are listed according to dosage in the first column 
2 Fluorescein amine was prepared through the courtesy of Dr. Klaus Hoffman of the De- 
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of Table I. At doses of 0.43 rag. Ab N  and below, the reaction was marked by a 
diffuse area of erythema and edema. At the lowest dosage, 0.03 mg. Ab N, the 
reaction in the gross was only slightly greater than that produced by an equal 
TABLE I 
Intensity of Gross Reaction as a Function of Quantity of Antibody Used* 
Mg. Ab N 
2.66 
1.20 
0.65 
0.43 
0.30 
0.03 
Soluble complexes 
++++ 
++++ 
++++ 
++++ 
÷++ 
++ 
+++ 
++ 
+++ 
4- 
+++ 
++ 
++ 
++ 
++ 
++ 
+ 
++ 
4- 
4- 
4- 
LPAt'§ 
++ 
+++ 
+++ 
+++ 
++ 
++ 
++ 
++ 
++ 
Rl'At'l[ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
* Intensity of reaction judged by the presence and amount of edema, erythema, hemor- 
rhage, necrosis, and tissue sloughing in the reaction site. 
§ LPA produced by i.d. injection of antibody followed by superimposed injection of 0.25 
mg. N  BSA in each case. 
0.4 ml. required at the 0.65 mg. Ab N  level. 
II RPA 8 mg. N  BSA i.v. followed by antibody i.d. 
volume of antiserum injected as a  control although,  as described below, the 
microscopic findings of this complex-produced reaction were similar in character 
to those induced by larger dosages. Using doses of 0.65 rag. Ab N  and above, 
the erythema and edema spread to large areas with diameters measuring up 
to 6 cm.  (Fig.  1). At these dosages, hemorrhage and necrosis occasionally oc- C. G. COCIIRANE AND  W.  0. WEIGLE  595 
curred.  Sloughing of the skin was observed at the 2.66 rag. Ab N dosage level 
(Fig.  2). 
The cutaneous reaction to soluble complexes was dompared to the local pas- 
sive Arthus (LPA)  3 and the reversed passive Arthus (RPA)  4 using the amount 
of antibody in terms of nitrogen as the common reference point. Quantities of 
antibody larger than 0.65 rag. Ab N  could not be used in the LPA and RPA 
reactions owing to the large volumes of antiserum required.  The comparative 
results are tabulated in Table I. It can be seen that the cutaneous reaction to 
complexes and the LPA are similar  in intensity at the dosage  levels shown. 
The LPA reactions reached their maximum at about 20 to 24 hours and were 
marked by diffuse erythema and edema.  They were indistinguishable  macro- 
scopically from the complex-produced  reactions  using equivalent amounts of 
antibody. On the contrary, the RPA reactions,  as seen in the 4th column of 
Table I were of maximal intensity at levels of as low as 0.30 rag. Ab N, which 
is in agreement with the results  obtained by Fischel and Kabat (5). It should 
be noted, however, that this evaluation was based on the degree of hemorrhage 
and necrosis produced in these lesions, which was the striking feature of the 
RPA reaction (Fig. 3). Actually the total amount of edema formed was nearly 
equal  in all three types of reactions,  being  concentrated about the injection 
site in the RPA reaction, while diffusely  spread in the complex and LPA lesions. 
Another striking difference was the time required for development of maximal 
intensity of reaction. The RPA reached its maximum within 5 to 8 hours, while, 
as stated previously,  the complex and LPA reactions  required  20 to 24 hours 
for full development. As is well known, this rapid development of reaction also 
occurred in the classical or active Arthus reactions in which actively sensitized 
rabbits  with circulating antibody were  given  intradermal injections of the 
homologous antigen. 
Control injections were made with each protein solution used in the manner 
described. In all cases in which control solutions of BSA were injected, a mild 
erythema developed  within 30 minutes, but subsided  with the dissemination 
of injected material leaving  a faint pale area about 1 cm. in diameter at 24 
hours. Injection of 0.3 ml. of the antisera used showed a diffuse erythema and 
edema within an hour. By 24 hours only a 1 to 2 cm. area of mild erythema 
and edema persisted.  Sites in which BSA-anti BSA precipitates were injected 
persisted for 48 hours as firm nodules  1 to 2 cm. in diameter with erythema 
localized over the injection site. The erythema was of low intensity, and necrosis 
was  not seen.  The sites  into which  heat-denatured BSA had been  injected 
persisted for 48 hours as small, firm nodules with only slight erythema noted. 
g. Microscopic Studies.--Microscopic  studies  were performed  on biopsies of 
reactions taken at 1, 5, 8, 24, and 48 hours and 5, 7, 9, and 11 days after the 
final injection. All tissues were stained as routine with hematoxylin and eosin. 
a LPA, local passive Arthus reaction. 
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(a) In the complex reactions, at all dosage levels, the earliest changes as seen 
in the 1, 5, and 8 hour specimens consisted of margination of polymorphonuclear 
leukocytes (polymorphs)  "along the endothelium of vessels and the presence 
of polymorphs in the tissue  around small vessels. However,  polymorphs did 
not accumulate in the vessel walls. By 8 hours, polymorphs had spread through- 
out the dermis in large numbers,  especially in the area immediately above the 
underlying muscle layer. Many of these leukocytes had become necrotic.  No 
especial intramural vascular accumulation was noted. Few vessels contained 
thrombi, with only an occasional capillary or small vein showing leukocyfic 
plugging. Larger vessels (over 20 microns in diameter) rarely showed thrombo- 
sis. This was true of sections at both 8 and 24 hours. An occasional small vein 
was necrotic at 8 hours. By 24 hours degeneration of the polymorphs was 
marked and many were seen containing large quantities of phagocytized ma- 
terial. Mononuclear ceils were now conspicuous, noted especially in perivascular 
areas.  At this time, necrosis of vessel wails was more commonly seen.  This 
appeared as a deep pink, amorphous change in the vessel wall typical of fibrinoid 
change,  involving either the entire circumference  or just one portion of the 
wail (Figs. 4, 5). At times, this necrotic area was limited to the outer portion 
of one segment of the vessel wall. Leukocytic infiltration of the necrotic areas 
was not a striking feature. The endothelial ceils appeared more prominent and, 
again,  thrombosis  was  uncommon in  the  affected  vessels.  Edema was  still 
present and hemorrhage from small vessels could be seen,  especially in the 
higher dosage levels. Frequently at 24 and 48 hours after injection, large, pink, 
acellular zones of tissue necrosis were found in the upper dermis corresponding 
to the necrotic zones seen in the gross. By 48 hours polymorphs were infre- 
quently seen, but mononuclear cells were common around vessels and through- 
out  the  dermis.  Sections taken  at  7  and  9  days  after  injection  revealed 
a perivascular  accumulation of mononuclear cells and only an occasional mature 
plasma cell. 
(b) The LPA biopsy sections revealed a histological sequence of events similar 
in all respects  to the soluble complex reactions. 
(c) However, the RPA and active Arthus reactions showed distinct differences 
from those in which  both  antigen and  antibody were  injected locally (the 
complex and LPA reactions).  In the RPA and active Arthns reactions,  which 
will  be  described  together,  the  characteristic microscopic  feature  was  the 
marked, immediate vascular inflammation. This appeared at 1 hour as a mar- 
gination of polymorphs along  the endothelial surface  and in the vessel wall. 
Also  seen  in occasional  vessel  walls  was a  light, pink  staining,  amorphous 
material that either replaced  or masked the normal cellular structures in the 
wall. This material was sometimes seen on the luminal side of the intact en- 
dothelial fining indicating that it might not be derived from the vessel wall. 
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masses of polymorphs were seen in the vessel walls along with this pink ma- 
terial forming the typical picture of the active Arthus or RPA lesion (Fig. 6). 
Thrombosis  in these reactions was frequent, especially in affected vessels, as 
opposed to the complex and LPA reactions in which thrombosis was infrequent. 
Hemorrhage and edema were also abundant by 5 hours as opposed to the com- 
plex and LPA sections. Polymorphs had spread out into the surrounding tissue 
and some had undergone degeneration.  At 8  hours,  the reactions  appeared 
much the same although more intense,  and by 24 hours,  areas  of acellular 
tissue necrosis were found in the upper dermis. At this time, perivascular and 
intravascular  mononuclear  cells were  conspicuous  while  polymorphs  were 
fewer in number than at 8 hours.  By 48 hours,  almost all the inflammatory 
cells were mononuclear in type, and from then on to 11 days after injection, a 
difference between the RPA and active Arthus was noted. In the active Arthus, 
mature plasma ceils were seen in abundance at 5 days and 11 days; while, in 
the RPA as in the complex and LPA reactions,  only occasional plasma cells 
were to be found. These results compare favorably  with those of Gell and Hinde 
(20). These workers found that Arthus reactions in rabbits in which antibody 
had been passively transferred did not show plasma cell concentration by day 5, 
while an Arthus reaction produced in actively sensitized rabbits showed marked 
plasma cell accumulation at day 5 and later. 
Microscopic studies of control sections in which antigen or antiserum were 
injected alone as described above revealed a mild to moderate diffuse infiltration 
of polymorphs in the dermis at 8 and 24 hours. Edema was minimal at 8 hours 
and not observable  at 24 hours and vascular necrosis  and hemorrhage were 
absent. Histologic  sections  of the sites  in which  BSA-anti-BSA precipitates 
had been injected revealed  clumps  of precipitated protein limited to the im- 
mediate area of injection. This precipitate was surrounded and partially invaded 
by a lining of polymorphs.  Vessels and other structures immediately adjacent 
to the precipitates were unaffected. Microscopic sections of the sites in which 
heat denatured BSA had been injected were similar except that less surrounding 
polymorph aggregation was seen. 
3. Fluorescence Studies.--The frozen biopsied reaction sites, as noted before, 
were sectioned  at 6 to 7 microns  on a freezing microtome,  fixed in an ethyl 
alcohol--ether mixture and then 95 per cent ethyl alcohol and after a  saline 
washing were overlaid  with a fluorescein-labelled antibody solution.  The sec- 
tions were then washed and observed using the fuorescence microscope. Using 
fluorescent anti-BSA, i.e. testing for the presence of BSA, the soluble complex 
reaction showed under low magnification diffuse, bright green fluorescence in 
the area of severe reaction. The fluorescence or BSA under high power magnifi- 
cation was of a granular nature, the protein being diffusely scattered through 
the dermis and subcutaneous tissue. A concentration of the BSA was seen at 
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seen. A study of the relationship  of the BSA to vessels was made by comparing 
localization  of the fluorescence under ultraviolet light with the position of 
vessels using phase microscopy of the same section or by studying the adjacent 
section stained with hematoxylin and eosin. It was found that while the BSA 
frequently came to lie in the vicinity of vessels, little, if any, could be seen in 
the vessel wails. This lack of vascular concentration of the antigen was noted 
not only in the case of normal vessels, but of special note, little or no BSA was 
found in the wails of vessels showing margination and diapedesis of polymorphs 
and in vessels in which necrosis in the wall was seen on the next section which 
was stained with hematoxylin and eosin (Fig. 7). In each case, however, the 
granular fluorescence marking the BSA could be seen in adjacent areas. Sections 
of the LPA reactions studied under identical conditions were indistinguishable 
from the complex reactions. 
This lack of concentration of BSA in the vessel wails of the complex and 
LPA reactions is in sharp contradistinction to the localization seen in both the 
RPA and classical or active Arthus reactions.  In the latter two, the affected 
vessels stand out on fluorescence microscopy  as bright, granular, green rings 
due to their contained BSA (Figs. 8 to 11). Actually, in many sections, little 
BSA was found other than that fixed in vessel walls. In sections of RPA or 
active Arthus reactions  taken 1 hour after injection,  BSA was found in small 
vessels while at 8 and 24 hours,  the larger vessels also contained BSA. This 
correlated with the size of the vessel affected as seen on hematoxylin  and eosin- 
stained sections. Vessels were occasionaily seen similar to those men~tioned in 
the microscopic  description  above  in which  pink,  amorphous material was 
seen within the lumen. This pink material was found to contain an abundance 
of BSA indicating that antigen and a.ntibody have combined in an area inde- 
pendent of cells. BSA could be found in sections taken through 24 hours after 
injection in ail four types of reactions studied, but in sections taken at 48 hours, 
BSA was rarely visualized. 
Attempts to study the localization  of rabbit globulin in similar sections of 
rabbit tissue were ditficult to interpret, since the presence of an abundance of 
rabbit proteins in the edema fluid of the reaction resulted in a large amount of 
generalized  tissue  fluorescence. Instead, guinea pigs  were  studied using the 
BSA-rabbit  anti-BSA system. RPA and soluble complex lesions were produced 
using 3 guinea pigs in each case. Sections of these lesions treated with fluorescent 
anti-BSA showed a distribution of the antigen similar to that seen in the rabbit 
sections. Using fluorescent sheep anti-rabbit globulin, a distribution of fluores- 
cence corresponding to the BSA localization was observed in both the complex 
and RPA reactions. It is to be noted that in the case of the complex reactions, 
the localized globulin represented  antibody, since it was that globulin only that 
had been bound to BSA in the washed precipitates.  The results indicate that, 
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in the tissue. The localized globulin in the RPA sections may include some 
non-antibody globulin as  well  as  specific  antibody. 
A  summary of the differences between the complex and LPA reactions on 
the one hand and the RPA and active Arthus lesions on the other are listed in 
Table II. It is seen that in the former two reactions, the antigen, and as is 
shown in the guinea pig studies, the antibody, were found diffusely  scattered in 
the dermis and subcutaneous tissues, with little, if any, in  the vessel walls; 
while the RPA and active Arthus reactions showed a predominant vessel wall 
accumulation. The complex and LPA lesions demonstrated less severity in the 
gross at the lower dosage levels and less hemorrhage, tissue necrosis, vascular 
reaction and thrombosis and fewer leukocytes in the damaged vessels.  More- 
TABLE  II 
Comparison of Cutaneous Reactions in Which Both A g and A b Are Injected Intradermally with 
Reactions in Which A  ~  or Ab is Present Intravenously 
I. Localization of antigen ............. 
2. Gross reaction at low dosages* ....... 
3. Time for maximal reaction  (hrs.)  ..... 
4. Degree of vascular reaction ......... 
5. Lcukocytes in vascular necrosis ...... 
6. Thrombosis  of vessels  ............... 
7. Hemorrhage ....................... 
Soluble  complexes  or LPA 
Diffusely scattered 
4- to ++ 
20-24 
Mild to moderate 
Few 
Occasional 
Mild 
RPA or active Arthus 
P~do~nantlyv~cu~r 
++++ 
5-8 
Ma~ed 
Marked 
Frequent 
Mar~d 
* Less than 0.43 mg. Ab N. 
over, the time required to reach the height of these two reactions was greater 
than that required in the case of the active Arthus and RPA reactions. 
4. Controls of Fluorescence  Studies.--Observations  were made in the active 
Arthus and RPA reactions to find if unaffected vessels contained BSA. In each 
case in which the vessel was not affected, application of fluorescent anti-BSA 
failed to produce fluorescence; i.e.,  BSA, in the vessel wall. Further, sites of 
injection of BSA into normal, unsensitized rabbit skin showed only pale, diffuse 
fluorescence at the most without specific localization. However, the possibility 
existed that the localization of BSA in the vessel walls of the active Arthus 
lesions  did  not  represent  specifically fixed  antigen,  but  rather  represented 
what one would expect to find when any protein contacted vessels damaged in 
a similar fashion. To study such a possibility, two BSA-sensitized rabbits were 
injected intradermally with a saline solution of 0.32 mg. N  BSA with 0.32 mg. 
N human gamma globulin (HGG) added as an unrelated protein; and conversely 
4 rabbits sensitized to HGG were injected with 0.30 mg. N HGG with 0.30 mg. 
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of the homologous antigen demonstrated the typical granular fluorescence  in 
affected vessel walls, but showed only the faint, diffuse presence of the unrelated 
proteins.  These results  indicate  that  the localization  of homologous antigen 
represents specific fixation of the antigen at the site of reaction. 
In all instances,  sections treated with non-fluorescent  anti-BSA before the 
fluorescent anti-BSA showed a marked decrease in intensity of fluorescence  as 
compared to an adjacent section stained first with an unrelated non-fluorescent 
antibody, e.g. non-fluorescent  anti-I-IGG,  and then fluorescent anti-BSA. This 
indicated  that  the fixation  of the  fluorescent antibody could be specifically 
inhibited. 
DISCUSSION 
The data presented in this report demonstrate that a single intracutaneous 
injection  of soluble antigen-antibody  complexes  is  capable of producing  an 
inflammatory reaction. With large doses, necrosis  and sloughing  of the tissue 
may be produced.  On microscopic examination  a  diffuse  infiltration  of the 
tissue with leukocytes is seen and necrosis  of vessel walls  is not infrequent. 
Further, these results are in keeping with the supposition (2--4) that antigen- 
antibody complexes are responsible  for the lesions that develop in serum sick- 
ness.  The  findings  of  C-ermuth  and. McKinnon  (7),  Trapani,  Garvey,  and 
Campbell  (8),  and Ishizaka and Campbell (9),  and Tokuda and Weiser (10) 
add support to this contention. However, the cutaneous response to the injec- 
tion of soluble antigen-antibody complexes need not necessarily be elicited by 
the complex of antigen and antibody as formed in dtro. To be sure,  following 
injection, dissociation and reassociation of antigen and antibody perhaps takes 
place and this process may be responsible for part or all of the tissue changes 
that occur. 
The comparison of the cutaneous reaction to soluble complexes with the local 
passive  Arthus  (LPA),  reversed  passive  Arthus  (RPA),  and  the  active  or 
classical  Arthus  reactions indicated  that  two general  types of reactions  oc- 
curred:  (a)  those resulting  from the injection of both antigen  and  antibody 
locally and (b) those in which either antigen or antibody were present in the 
blood stream, and the other reactant was injected locally.  The dissimilarities 
between these two types of reactions are summarized in Table II.  In brief, 
when either reactant is found circulating,  the antigen, and in all likelihood  the 
antibody, become localized in vessel walls; while when both are injected locally, 
the antigen and antibody are found diffusely scattered in the dermis and sub- 
cutaneous tissue, but vessels contain little, if any, of these components. Further, 
the reactions in which both reactants are injected locally show less frequent 
vascular necrosis,  little vascular  thrombosis,  only mild hemorrhage  in most 
instances, and  absence of tissue necrosis  at lower dosage levels. On the other 
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is present  intravenously  exhibit  extreme vascular,  thrombotic,  hemorrhagic, 
and necrotic changes.  It would appear that when one of the reactants is present 
intravenously and  the other  is  injected intradermally,  as is  the case in  the 
RPA  and  active  Arthus,  the  locally injected  material  diffuses  through  the 
tissue contacting  sizeable  amounts  of the other reactant  first at  the site of 
vessels.  The  localization  of antigen  and  in  all  probability antibody  (as  was 
demonstrated in the RPA in guinea pigs) in vessel walls was found to be the 
characteristic feature of these reactions. Some of the reaction also takes place 
in the interstitial space, but as demonstrated in the fluorescent antibody studies, 
this is of not great proportion. While the antigen and antibody combine in the 
smallest vessels at first (1 to 2 hours), soon larger ones are involved as noted 
in sections taken 5 hours after injection. It is believed that this predominant 
vessel wall locus of combination is responsible for the marked vascular changes 
that  then take place as described in the earliest stages in vivo  by Abell and 
Schenck (21) and others (22, 23),  and which end in marked intravascular ac- 
cumulation of leukocytes, thrombosis, necrosis of vessel walls, hemorrhage,  and 
tissue death. In contrast to this, when both reactants are injected intradermally, 
the  antigen-antibody  combination  is  present  in  the  interstitial  space  pre- 
dominantly. While capillaries  are probably infiltrated by the antigen and anti- 
body in the central portion of the reaction,  larger vessels are conspicuously 
devoid of the localization of the antigen and antibody, possibly by virtue of 
increased tissue resistance of the normal vessel wall. However, damage to the 
larger vessel walls apparently takes place, with little or no concentration of the 
antigen-antibody combination in the vessel walls but with the reactants present 
in the adjacent interstitial space. Following this vascular damage, the secondary 
events, i.e.  the thrombosis, hemorrhage,  and tissue necrosis,  may take place. 
However, neither the primary vascular damage nor the secondary events are 
as severe as those seen in reactions in which antigen  or antibody is present 
intravenously. 
As  noted  above,  in  both  the  complex-produced  and  LPA  reactions,  the 
antigen was found diffusely scattered in granular clumps throughout the dermis 
and  subcutaneous tissue.  In  particular,  damaged vessels  contained  little,  if 
any, BSA. This suggested that the antigen-antibody combination, while present 
in tissue adjacent to a vessel was capable of inducing reaction and necrosis  of 
the vessel wall; or perhaps that very small amounts of antigen and antibody 
within the vessel wall,  but not detectable by our technique,  were capable of 
inducing vascular damage. That such vascular damage might be mediated by 
factors liberated  as a  result of the presence of antigen  and  antibody in the 
vicinity of vessels seems possible in view of the increasing  body of evidence 
indicating that physiologically active substances are released from tissues and 
body fluids when antibody and antigen combine. 
It was noted in these experiments that the injected antigen, in each type of 602  SOLUBLE  ANTIGEN-ANTIBODY  COMPLEXES 
reaction,  was  rarely observable  in  sections  taken 48  hours  after injection. 
Studies by Korngold, Stahly, Dodd, and Myers (24) following the loss of 1  TM 
BSA from an intradermai site in a sensitized rabbit, demonstrated that between 
20 and 30 per cent of the antigen persisted at 24 hours. In similar studies (25), 
we have confirmed this data and also found that approximately half of this 
amount persisted  at 48  hours.  However,  as  shown in this report using the 
fluorescent antibody technique, the BSA does not persist for 48 hours in de- 
tectable amounts or detectable form in the specific  site of the vessel wall in 
the active Arthus lesion. 
SUMMARY 
The in vivo activity of soluble antigen-antibody complexes was tested by a 
single intradermal injection in rabbits. Skin reactions were obtained marked by 
erythema, induration, and occasionally hemorrhage and necrosis. Microscopi- 
cally, diffuse inflammation and occasional vascular necrosis could be found at 
all dosages. This indicates that soluble antigen-antibody complexes are phlogo- 
genic and provides support for the suggestion that complexes are responsible 
for the lesions seen in serum sickness. 
The reactions were similar in severity to local passive Arthus (LPA) reactions 
at equal dosages of antibody in the dosage range studied. 
BSA antigen could be found in large concentrations in affected vessel walls of 
both reverse passive Arthus  (RPA)  and active or classical Arthus reactions. 
It is suggested that this predominantly vascular localization of antigen might 
bring about the relative severity of the RPA and active Arthus reactions, as 
contrasted to the complex and LPA reactions. 
The finding of affected vessels in the complex and LPA reactions containing 
little or  no  antigen and  antibody, while these  components were present in 
adjacent areas,  suggests  that  the  antigen-antibody combination may cause 
vascular reaction and damage by the release of physiologically active mediators 
from the tissue or tissue fluid. 
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EXPLANATION  OF PLATES 
PLATE 37 
FIG. 1.  Cutaneous reaction to soluble antigen-antibody complexes (BSA-anfi BSA) 
24 hours after intradermal (i.d.) injection of 0.65 rag. Ab N dosage. Note edema and 
erythema. X  ~. 
FIG. 2.  Cutaneous reaction to  soluble  BSA-anti BSA  complexes,  24 hours after 
i.d.  injection of dosage 2.66 rag. Ab N. The two sites at the left are the areas of in- 
jection of complexes showing necrosis and sloughing, while the two sites on the right 
are antiserum control injections.  X  ~. 
FIG. 3.  Reversed passive Arthus reaction (RPA). Photomicrograph taken 24 hours 
after i.d. injection of 0.30 rag. anti-BSA N into a rabbit with circulating BSA. Severe 
hemorrhage and necrosis are present at this dosage of antibody.  X  ~. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 108  PLATE  37 
(Cochrane and Weigle:  Soluble antigen-antibody complexes) PLATE 38 
FIG. 4.  Necrotic vessel seen in cutaneous lesion of soluble complexes. Note hemor- 
rhage and relatively few inflammatory cells in the necrotic vessel wall.  Hematoxylin 
and eosin stain.  X  240. 
FIG.  5.  Another vessel  (on  the  left)  from  a  soluble complex cutaneous  reaction 
showing necrosis of a  portion of the wall only. Note the absence of thrombosis. He- 
matoxylin and eosin stain.  X  360. THE  JOURNAL OF  EXPERIMENTAL MEDICINE VOL.  108  PLATE 38 
(Cochrane and Weigle: Soluble antigen-antibody  complexes) PLATE 39 
FIC. 6.  Vessel in a section of a reversed passive Arthus, 5 hours after i.d.  injection 
of 0.30  rag.  Ab N,  showing inflammation of  the  vessel wall and  perivascular area. 
Hematoxylin and eosin stain.  X  360. 
FIG.  7.  Fluorescence photomicrograph  of a  damaged  vessel in  a  soluble complex 
skin  lesion.  Granular  white  areas  mark  the  presence  of  BSA.  Arrow  marks  outer 
portion of vessel wall. The wall contains no detectable BSA while an abundance  of 
the antigen is seen in surrounding areas.  Sections taken above and  below this failed 
to  reveal BSA in  the vessel wall.  X  440. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 108  PLA~E  39 
(Cochrane and Weigle: Soluble antigen-antibody complexes) PLATE  40 
Fla.  8.  Vessel  in  an  active  or  classical  Arthus  reaction,  8  hours  after  injection, 
showing inflammation of the vessel wall. Hematoxylin and  eosin stain.  X  280. 
FIG. 9.  Fluorescence photomicrograph  of a  similar vessel as seen in Fig. 8.  Section 
treated with anti-BSA to detect the presence of BSA. The BSA is found concentrated 
in  the  area  of  vascular  inflammation.  A  similar concentration  of antigen  is seen in 
RPA sections.  X  240. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 108  PLATE  40 
(Cochrane and Weigle: Soluble antigen-antibody complexes) PLATE 41 
FIG. 10.  Microscopic section of an active Arthus reaction, 2 hours after injection. 
Early inflammatory changes are seen. Hematoxylin and eosin stain.  X  360. 
FIG. 11.  Fluorescence photomicrograph of a vessel with early inflammatory changes 
similar to that seen in Fig. 10. The BSA is localized to the vessel wall and little spread- 
ing is seen.  X  440. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 108  PLATE  41 
(Cochrane and Weigle: Soluble antigen-antibody complexes) 